Data Bridge Market Research analyses that the point-of-care testing (POCT) market which was USD 29 billion in 2021, would rocket up to USD 64.46 billion by 2029, and is expected to undergo a CAGR of 10.5% during the forecast period 2022 to 2029. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Get Your Sample Today: https://www.databridgemarketresearch.com/request-a-sample/?dbmr=apac-point-care-testing-poct-market
Market Analysis and Insights
POC tests are not as highly preferred as central laboratory tests because of low volume and high cost. This puts additional strain on the billing system, which must give distinct codes for POC tests. This might result in billing errors by inexperienced or newly hired employees, as well as failure to enter data into the data management system due to mismatched test codes.
Chronic diseases and acute infections are on the rise in developing countries, owing to a lack of health awareness, poor medical infrastructure, and a sedentary lifestyle, among other causes. As a result of these circumstances, diagnosis and treatment are delayed, as is the quality of care obtained. The need for point-of-care tests for rapid diagnosis is growing due to their convenience of use, cost-effectiveness, and small product size.
Buy Now Access Full Report:- https://www.databridgemarketresearch.com/reports/apac-point-care-testing-poct-market
Asia-Pacific Point-of-Care Testing (POCT) Market Scope
The point-of-care testing (POCT) market is segmented on the basis of product, technology, prescription, application, end-user and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Technology
· Lateral flow assays
· Dipsticks
· Microfluidics
· Molecular diagnostics
· Immunoassays
· Agglutination assays
· Flow-through
· Solid phase
· Biosensors
Prescription
· OTC testing
· Prescription-based testing
Application
· Cardio metabolic testing
· Infectious disease testing
· Nephrology testing
· Drug-of-Abuse (DoA) testing
· Blood glucose testing
· Pregnancy testing
· Cancer biomarker testing
· Other applications
End-user
· Hospitals
· Diagnostic centers
· Research laboratories
· Home-care settings
· Others
Asia-Pacific Point-of-Care Testing (POCT) Market Country Level Analysis
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
The countries covered in the point-of-care testing (POCT) market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).China is expected to dominate the market because point-of-care testing (POCT) products in China have a massive application space in the fields of hospital operation, emergency department, intensive care, chronic disease prevention and control, public health emergencies, county-level medical institution construction, and new rural supportive medical care.
Browse The Table of Contents And List of Figures: https://www.databridgemarketresearch.com/toc/?dbmr=apac-point-care-testing-poct-market
Major TOC of the Asia-Pacific Point-of-Care Testing (POCT) Market Report
Chapter One:
MARKET SEGEMENTATION
EXECUTIVE SUMMARY
PREMIUM INSIGHTS
MARKET OVERVIEW
Competitive Landscape and Asia-Pacific Point-of-Care Testing (POCT) Market Share Analysis
The point-of-care testing (POCT) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Asia-Pacific presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to point-of-care testing (POCT) market.
Some of the major players operating in the point-of-care testing (POCT) market are:
· Abbott (U.S)
· F. Hoffmann-La Roche Ltd (Switzerland)
· BD (U.S)
· Siemens Healthcare Private Limited (Germany)
· Bio-Rad Laboratories, Inc. (U.S)
· Danaher (U.S)
· Sekisui Diagnostics (U.S)
· Trinity Biotech (Ireland)
· bioMérieux (France)
· EKF Diagnostics (Germany)
· AccuBioTech Co., Ltd. (C
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best Market opportunities and foster efficient information for your business to thrive in the Market
Contact:
Data Bridge Market Research
Tel: +1-888-3895-2818
Email: Sopan.gedam@databridgeMarket research.com
Browse Related Reports@
